Clinical Trials & Results

Search or filter the listing below to find a trial or results of a completed trial.

View Actively Recruiting Clinical Trials

Click here to see trials currently recruiting participants

Filter

Health Condition

Toggle

Study Status

Toggle

Age group

Toggle

Gender

Toggle

Phase

Toggle

Study Types

Toggle

All Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

Clear Filters

Laquinimod Study in Active Crohn's Disease

inflammation-icon.png
Condition(s):
Crohn's Disease
Status:
Completed
Requirements:
18 Years to 75 Years
Interventions:
Drug: Laquinimod | Other: placebo
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Multicenter Trial For Patients With Acute Crohn's Disease

inflammation-icon.png
Condition(s):
Crohn's Disease
Status:
Completed
Requirements:
18 Years and older
Interventions:
Drug: etiprednol dicloacetate
Learn more Please refer to ClinicalTrials.gov for a description of the trial

Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

inflammation-icon.png
Condition(s):
Crohn's Disease
Status:
Completed
Requirements:
Adult
Interventions:
Drug: TEV-48574 | Drug: Placebo
Learn more Primary objectives: The primary objective is to evaluate the efficacy and dose response of 3 different dose regimens of TEV-48574 in adult participants with IBD (moderate to severe Ulcerative Colitis (UC) or Crohn's Disease (CD) as assessed by induction of clinical remission (UC) and endoscopic response (CD). Secondary objectives: To evaluate the efficacy and dose response of the 3 different dose regimens as assessed by multiple standard measures. To evaluate the safety and tolerability of the 3 different dose regimens. To evaluate the immunogenicity of the 3 different dose regimens. The study will consist of a screening period of up to 6 weeks (42 days), a 14-week treatment period, and a 4-week follow-up period.